Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Focusrite warns on FY profits amid 'challenging market conditions'

(Sharecast News) - Audio products business Focusrite warned on Monday that full-year revenue and profits would be lower than consensus estimates as a result of "challenging market conditions" and continued weakness in Asia. Focusrite said revenues for the year ending 31 August were now anticipated to be no less than £155.0m, while underlying earnings were pegged to be in the range of £27.0m to £30.0m, with a heavier weighting towards H2 than in FY23. Consensus estimates for sales sat at £182.0m, while forecasts for EBITDA were £38.0m.

The AIM-listed group said its first-half performance was impacted by "similar factors across the group's geographic regions", noting that the global content creation market "continues to struggle" due to a number of macroeconomic issues. Content creation revenue in Asia showed "particular continued weakness", with now 18 months of continuous decline, the largest negative impacts being in China and Japan, and no improvement likely to take place in the remainder of the year.

However, notwithstanding the firm's "cautious outlook" for the current financial year, Focusrite said it remains "well-positioned for future growth", when market conditions in the content creation market improve, with a clear focus on increasing market share, and delivering new products as well as making targeted acquisitions.

As of 1300 GMT, Focusrite shares were down 27.34% at 279.75p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Goldman Sachs downgrades SSP to 'sell', prefers WH Smith
(Sharecast News) - Goldman Sachs downgraded SSP on Monday to 'sell' from 'neutral' "on a relative basis" as it took a look at European travel concessions.
UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.